23rd Mar 2021 12:24
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 22 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,804,555 | 1.40% | 184,156 | 0.14% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
102,935 | 0.08% | 7,066 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
TOTAL: |
|
|
|
| |
1,913,590 | 1.48% | 197,322 | 0.15% | ||
|
|
|
|
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 221.4800 USD |
Purchase | 5 | 220.1000 USD |
Purchase | 50 | 221.3200 USD |
Purchase | 60 | 220.5100 USD |
Purchase | 70 | 220.9300 USD |
Purchase | 100 | 221.0800 USD |
Purchase | 100 | 220.6400 USD |
Purchase | 102 | 221.1845 USD |
Purchase | 200 | 220.8750 USD |
Purchase | 253 | 220.9212 USD |
Purchase | 290 | 220.6220 USD |
Purchase | 294 | 221.1658 USD |
Purchase | 300 | 220.9800 USD |
Purchase | 335 | 220.9880 USD |
Purchase | 400 | 221.0225 USD |
Purchase | 500 | 221.1490 USD |
Purchase | 600 | 221.1562 USD |
Purchase | 700 | 220.8757 USD |
Purchase | 700 | 220.9907 USD |
Purchase | 734 | 220.7391 USD |
Purchase | 757 | 221.1200 USD |
Purchase | 900 | 221.0255 USD |
Purchase | 1,045 | 220.8565 USD |
Purchase | 1,244 | 221.2708 USD |
Purchase | 1,464 | 220.7890 USD |
Purchase | 3,137 | 220.8000 USD |
Purchase | 3,265 | 220.8172 USD |
Purchase | 3,786 | 220.6028 USD |
Purchase | 4,325 | 220.7105 USD |
Purchase | 5,449 | 220.7370 USD |
Purchase | 5,556 | 220.5726 USD |
Purchase | 6,132 | 220.0496 USD |
Purchase | 9,703 | 220.9688 USD |
Purchase | 14,056 | 221.0305 USD |
Purchase | 20,014 | 220.7996 USD |
Sale | 9 | 221.6800 USD |
Sale | 11 | 221.6700 USD |
Sale | 20 | 220.9100 USD |
Sale | 35 | 220.9288 USD |
Sale | 41 | 220.0200 USD |
Sale | 56 | 220.7600 USD |
Sale | 57 | 221.1200 USD |
Sale | 60 | 220.5100 USD |
Sale | 70 | 220.9300 USD |
Sale | 100 | 220.7850 USD |
Sale | 100 | 220.9450 USD |
Sale | 100 | 220.0300 USD |
Sale | 100 | 220.3200 USD |
Sale | 128 | 220.0000 USD |
Sale | 140 | 220.6014 USD |
Sale | 162 | 220.3729 USD |
Sale | 165 | 220.7864 USD |
Sale | 200 | 221.0025 USD |
Sale | 200 | 220.5750 USD |
Sale | 293 | 220.5431 USD |
Sale | 294 | 221.1658 USD |
Sale | 300 | 221.0600 USD |
Sale | 314 | 220.1592 USD |
Sale | 400 | 220.9562 USD |
Sale | 760 | 220.8725 USD |
Sale | 946 | 220.1760 USD |
Sale | 1,145 | 220.8760 USD |
Sale | 1,260 | 220.3911 USD |
Sale | 1,685 | 220.4105 USD |
Sale | 1,806 | 220.8003 USD |
Sale | 2,356 | 220.8290 USD |
Sale | 3,031 | 220.8000 USD |
Sale | 3,205 | 220.8653 USD |
Sale | 5,275 | 220.7349 USD |
Sale | 5,484 | 220.6346 USD |
Sale | 7,762 | 220.9789 USD |
Sale | 7,789 | 220.2871 USD |
Sale | 20,000 | 221.0466 USD |
Sale | 20,851 | 220.8076 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 23 Mar 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection |
|
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price |
| date |
|
| to which the option |
|
|
|
|
| or derivative |
|
|
|
|
| relates |
|
|
|
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210323005678/en/
Copyright Business Wire 2021
Related Shares:
Barclays